Boston Scientific (BSX) Construction in Progress (2009 - 2026)
Boston Scientific (BSX) reported Construction in Progress of $1.1 billion for Q1 2026, up 10.51% on a YoY basis from $1.0 billion in Q1 2025, and down 3.96% sequentially from $1.2 billion in Q4 2025.
Boston Scientific (BSX) Construction in Progress (2009 - 2026) Analysis & Trends
Boston Scientific (BSX) has 18 years of Construction in Progress data on file, last reported at $1.1 billion in Q1 2026.
- For the quarter ending Q1 2026, Construction in Progress rose 10.51% year-over-year to $1.1 billion; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (up 10.51% YoY), and the FY2025 full-year result was $1.2 billion, up 12.17% from the prior year.
- Construction in Progress slipped to $1.1 billion in Q1 2026, from $1.2 billion in the prior quarter.
- In the past five years, Construction in Progress ranged from a high of $1.2 billion in Q4 2025 to a low of $513.0 million in Q3 2022.
- A 5-year average of $820.4 million and a median of $880.0 million in 2024 frame the typical range for Construction in Progress.
- Across the five-year window, Construction in Progress surged 55.2% in 2024 and dropped 3.11% in 2025, its largest moves.
- Tracing BSX's Construction in Progress over 5 years: stood at $598.0 million in 2022, then surged by 43.31% to $857.0 million in 2023, then grew by 20.77% to $1.0 billion in 2024, then gained by 12.17% to $1.2 billion in 2025, then decreased by 3.96% to $1.1 billion in 2026.
- Business Quant data shows BSX's Construction in Progress at $1.1 billion in Q1 2026, $1.2 billion in Q4 2025, and $936.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.12 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 509.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.12 Bn |
| Dec 31, 2025 | 1.16 Bn |
| Sep 30, 2025 | 936.00 Mn |
| Jun 30, 2025 | 1.04 Bn |
| Mar 31, 2025 | 1.01 Bn |
| Dec 31, 2024 | 1.04 Bn |
| Sep 30, 2024 | 966.00 Mn |
| Jun 30, 2024 | 897.00 Mn |
| Mar 31, 2024 | 880.00 Mn |
| Dec 31, 2023 | 857.00 Mn |
| Sep 30, 2023 | 691.00 Mn |
| Jun 30, 2023 | 604.00 Mn |
| Mar 31, 2023 | 567.00 Mn |
| Dec 31, 2022 | 598.00 Mn |
| Sep 30, 2022 | 513.00 Mn |
| Jun 30, 2022 | 537.00 Mn |
| Mar 31, 2022 | 539.00 Mn |
| Dec 31, 2021 | 605.00 Mn |
| Sep 30, 2021 | 465.00 Mn |
| Jun 30, 2021 | 432.00 Mn |